This week, it was announced on the OMB website that the HRSA Bureau of Primary Health Care (BPHC) has submitted for OMB review a proposed regulation that would rescind the Trump-era rule around FQHCs, insulin and EpiPen’s. While this is a good sign, please know that there are several steps that must be taken before the regulation could actually be rescinded: the Proposed Rule must be published; there will be a public comment period and then BPHC will review the comments and issue a Final Rule.
